Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ettore Luzi

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2009
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumorsAlberto Falchetti, Francesca Marini, Ettore Luzi, et al.
Antisense & Nucleic Acid Drug Development|May 23, 2002
Phosphodiester oligonucleotides inhibit mitosis and trigger apoptosis by a non-antisense, p53-mediated mechanismLaura Papucci, Nicola Schiavone, Martino Donnini, et al.
Orphanet Journal of Rare Diseases|October 4, 2006
Multiple endocrine neoplasia type 1Francesca Marini, Alberto Falchetti, Francesca Del Monte, et al.
Current Medical Research and Opinion|August 9, 2008
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosisFrancesca Marini, Alberto Falchetti, Sandra Silvestri, et al.
Orphanet Journal of Rare Diseases|November 16, 2006
Multiple endocrine neoplasia type 2Francesca Marini, Alberto Falchetti, Francesca Del Monte, et al.
Cancer Gene Therapy|March 15, 2003
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozymeEttore Luzi, Laura Papucci, Nicola Schiavone, et al.
Genome Biology|May 8, 2016
RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cellsLuca Pandolfini, Ettore Luzi, Dario Bressan, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|October 18, 2013
COL1A1 Sp1 variation and bone phenotypes in an Italian populationFrancesca Marini, Simone Parri, Laura Masi, et al.
Journal of Visualized Experiments : Jove|October 22, 2016
Establishment of Cancer Stem Cell Cultures from Human Conventional OsteosarcomaGaia Palmini, Roberto Zonefrati, Carmelo Mavilia, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 27, 2016
Osteogenic differentiation of adipose tissue-derived mesenchymal stem cells on nanostructured Ti6Al4V and Ti13Nb13ZrFrancesca Marini, Ettore Luzi, Sergio Fabbri, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2009
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumorsAlberto Falchetti, Francesca Marini, Ettore Luzi, et al.
Antisense & Nucleic Acid Drug Development|May 23, 2002
Phosphodiester oligonucleotides inhibit mitosis and trigger apoptosis by a non-antisense, p53-mediated mechanismLaura Papucci, Nicola Schiavone, Martino Donnini, et al.
Orphanet Journal of Rare Diseases|October 4, 2006
Multiple endocrine neoplasia type 1Francesca Marini, Alberto Falchetti, Francesca Del Monte, et al.
Current Medical Research and Opinion|August 9, 2008
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosisFrancesca Marini, Alberto Falchetti, Sandra Silvestri, et al.
Orphanet Journal of Rare Diseases|November 16, 2006
Multiple endocrine neoplasia type 2Francesca Marini, Alberto Falchetti, Francesca Del Monte, et al.
Cancer Gene Therapy|March 15, 2003
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozymeEttore Luzi, Laura Papucci, Nicola Schiavone, et al.
Genome Biology|May 8, 2016
RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cellsLuca Pandolfini, Ettore Luzi, Dario Bressan, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|October 18, 2013
COL1A1 Sp1 variation and bone phenotypes in an Italian populationFrancesca Marini, Simone Parri, Laura Masi, et al.
Journal of Visualized Experiments : Jove|October 22, 2016
Establishment of Cancer Stem Cell Cultures from Human Conventional OsteosarcomaGaia Palmini, Roberto Zonefrati, Carmelo Mavilia, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 27, 2016
Osteogenic differentiation of adipose tissue-derived mesenchymal stem cells on nanostructured Ti6Al4V and Ti13Nb13ZrFrancesca Marini, Ettore Luzi, Sergio Fabbri, et al.
Pageof 3